0000950170-24-020321.txt : 20240226
0000950170-24-020321.hdr.sgml : 20240226
20240226172100
ACCESSION NUMBER: 0000950170-24-020321
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240222
FILED AS OF DATE: 20240226
DATE AS OF CHANGE: 20240226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sullivan Keith J
CENTRAL INDEX KEY: 0001417973
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38546
FILM NUMBER: 24680255
MAIL ADDRESS:
STREET 1: C/O RELIANT TECHNOLOGIES, INC.
STREET 2: 464 ELLIS STREET
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Neuronetics, Inc.
CENTRAL INDEX KEY: 0001227636
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3222 PHOENIXVILLE PIKE
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 877-600-7555
MAIL ADDRESS:
STREET 1: 3222 PHOENIXVILLE PIKE
CITY: MALVERN
STATE: PA
ZIP: 19355
FORMER COMPANY:
FORMER CONFORMED NAME: NEURONETICS INC
DATE OF NAME CHANGE: 20030416
4
1
ownership.xml
4
X0508
4
2024-02-22
0001227636
Neuronetics, Inc.
STIM
0001417973
Sullivan Keith J
C/O NEURONETICS, INC.
3222 PHOENIXVILLE PIKE
MALVERN
PA
19355
true
true
false
false
President and CEO
false
Common Stock
2024-02-22
4
S
false
20851
3.23
D
1413320
D
Common Stock
2024-02-23
4
S
false
20750
3.23
D
1392570
D
The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award.
The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.10 to $3.32. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.10 to $3.34. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ W. Andrew Macan, as Attorney-in-Fact
2024-02-26